Signaling Related Science – Scientific Sessions 2016

November 12–16, 2016
New Orleans, Louisana

LBCT.01 - Big Trials for Big Questions

Steven E Nissen

Cardiovascular Outcomes With Celecoxib vs. Ibuprofen or Naproxen: The Precision Trial
Steven E Nissen | Cleveland Clinic, Cleveland, OH

RESULTS: In a non-inferiority cardiovascular safety comparison of the COX-2 selective inhibitor celecoxib to non-selective NSAID’s, similar primary endpoint outcomes were seen in this trial at these doses for these drugs.